• Gilead Sciences leads in HIV treatments, facing competition from other drug companies. $Gilead Sciences(GILD.US)
• The stock market is experiencing a sell-off, particularly in AI-related stocks. • CrowdStrike is expanding into AI Detection and Response, boosting its stock performance. • Upcoming earnings reports from Google, Tesla, and Intel are critical for the AI sector. • The semiconductor market is struggling, with chip stocks entering bear territory. • Biotech stocks remain strong despite the downturn in AI stocks.The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments